Arabo A. Avanes

Arabo A. Avanes

Auto-generated profile, based on publicly available information

Arabo A. Avanes

Biochemistry, Molecular, Cellular, and Developmental Biology Graduate Program

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JTJeremy R. Tuck
Jeremy R. Tuck
LDLee E. Dunlap
Lee E. Dunlap
YKYara A. Khatib
Yara A. Khatib
CHCassandra J. Hatzipantelis
Cassandra J. Hatzipantelis
SNSammy Weiser Novak
Sammy Weiser Novak
DODavid E. Olson
David E. Olson
Decreased dendritic spine density in the cortex is a key pathological feature of neuropsychiatric diseases including depression, addiction, and schizophrenia (SCZ). Psychedelics possess a remarkable ability to promote cortical neuron growth and increase spine density; however, these compounds are contraindicated for patients with SCZ or a family history of psychosis. Here, we report the molecular design and de novo total synthesis of (+)-JRT, a structural analogue of lysergic acid diethylamide (LSD) with lower hallucinogenic potential and potent neuroplasticity-promoting properties. In addition to promoting spinogenesis in the cortex, (+)-JRT produces therapeutic effects in behavioral assays relevant to depression and cognition without exacerbating behavioral and gene expression signatures relevant to psychosis. This work underscores the potential of nonhallucinogenic psychoplastogens for treating diseases where the use of psychedelics presents significant safety concerns.

1 February 2019 in Biochemical Pharmacology
Verified
Journal Article
Closed access
AAArabo Avanes
Arabo Avanes
GLGal Lenz
Gal Lenz
JMJamil Momand
Jamil Momand

6 February 2025 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
RIRishab N. Iyer
Rishab N. Iyer
DFDavid Favela
David Favela
ADAndras Domokos
Andras Domokos
GZGuoliang Zhang
Guoliang Zhang
AAArabo A. Avanes
Arabo A. Avanes
DODavid E. Olson
David E. Olson

1 October 2021 in Gene
Verified
Journal Article
Open access
RMRabi Murad
Rabi Murad
AAArabo Avanes
Arabo Avanes
XMXinyi Ma
Xinyi Ma
SGShuhui Geng
Shuhui Geng
AMAli Mortazavi
Ali Mortazavi
JMJamil Momand
Jamil Momand
We set out to uncover transcriptome and chromatin landscape changes that occur in HER2+ breast cancer (BC) cells upon acquiring resistance to trastuzumab. RNA-seq analysis was applied to two independently-derived BC cell lines with acquired resistance to trastuzumab (SKBr3.HerR and BT-474HerR) and their parental drug-sensitive cell lines (SKBr3 and BT-474). Chromatin landscape analysis indicated that the most significant increase in accessibility in resistant cells occurs in PPP1R1B within a segment spanning introns 1b through intron 3. Footprint analysis of this segment revealed that FoxJ3 (within intron 2) and Pou5A1/Sox2 (within inton 3) transcription factor motifs are protected in resistant cells. Overall, 344 shared genes were upregulated in both resistant cell lines relative to their parental counterparts and 453 shared genes were downregulated in both resistant cell lines relative to their parental counterparts. In resistant cells, genes associated with autophagy and mitochondria organization are upregulated and genes associated with ribosome assembly and cell cycle are downregulated relative to parental cells. The five top upregulated genes in drug-resistant breast cancer cells are APOD, AZGP1, ETV5, ALPP, and PPP1R1B. This is the first report of increased chromatin accessibility within PPP1R1B associated with its t-Darpp transcript increase, and points to a possible mechanism for its activation in trastuzumab-resistant cells.

5 October 2023 in JACS Au
Verified
Journal Article
Open access
WCWinston L. Chow
Winston L. Chow
MGMonica A. Gonzalez
Monica A. Gonzalez
AAArabo A. Avanes
Arabo A. Avanes
DODavid E. Olson
David E. Olson
Tropane alkaloids are an important class of biologically active small molecules characterized by their 8-azabicyclo[3.2.1]octane core. Because of their numerous medicinal applications, microbial biosynthesis and a variety of chemical syntheses have been designed for individual family members. However, current approaches are not amenable to late-stage structural diversification at N8, C3, C6, or C7, positions that are critical for modulating the biological properties of these molecules. Here, we describe a general approach to the synthesis of tropane alkaloids and their analogues that relies on the construction of the 8-azabicyclo[3.2.1]octane core through aziridination of a cycloheptadiene intermediate, followed by vinyl aziridine rearrangement. Using this strategy, we synthesized six tropane alkaloids and several analogues in only 5-7 steps. Given that the tropane alkaloid scopolamine has been reported to promote structural neuroplasticity and produce antidepressant effects, we tested five tropane-containing compounds for their ability to promote dendritic spine growth in cultured cortical neurons. We found that the orientation of the C3 substituent may play a role in the psychoplastogenic effects of tropane alkaloids. Our work provides a robust platform for producing tropane analogs for future structure-activity relationship studies.

13 August 2025 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
AAArabo A. Avanes
Arabo A. Avanes
HWHunter T. Warren
Hunter T. Warren
ASAbinaya Senthil
Abinaya Senthil
DODavid E. Olson
David E. Olson